EXOZ - eXoZymes Quarterly EPS earnings growth

invizyne.com - graphic logo of issuer EXOZ

eXoZymes Inc (EXOZ) relies on external CRO and CMO contractors, fully delegating synthesis and testing. The company's innovations enable the synthesis of complex molecules without bacteria, accelerating drug release. The quarterly EPS shift on the GURU.Markets chart illustrates profit dynamics, where the -18.10 level reflects the current magnitude. Growth prospects are based on patents and the successful scaling of the cell-free platform to industrial volumes.

invizyne.com (EXOZ) Year-over-year earnings per one share growth for the last 12 months: for the period 02/13/2025 - 11/14/2026

Comprehensive metric breakdowns and analytics for invizyne.com (EXOZ)

- share price and expert price forecast:
Stock Price Invizyne Technologies, Inc.|EXOZ - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Invizyne Technologies, Inc.|EXOZ - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share eXoZymes|EXOZ - Accounting Value of Company|Market Capitalization to Book Value Ratio invizyne.com|EXOZ - Company Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio eXoZymes Inc|EXOZ - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Invizyne|EXOZ - Company Cumulative Debt|Debt to Book Value Invizyne|EXOZ - Long-Term Liabilities|Company Current Liabilities eXoZymes|Quick Liquidity invizyne.com
- earnings and market multiples details:
EXOZ - Net Income|Projected Future Earnings eXoZymes Inc|EXOZ - Market Cap to Earnings|Future Price to Earnings invizyne.com|EXOZ - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio eXoZymes Inc|EXOZ - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) eXoZymes|EXOZ - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months invizyne.com|EXOZ - Earnings per share growth this year|Earnings growth forecast for next year eXoZymes Inc
- sales revenue and business income indicators:
EXOZ - Company Sales|Projected Sales Volume invizyne.com|EXOZ - Price to Sales|Forward Price-to-Revenue Multiple Invizyne Technologies
Comprehensive company analysis:eXoZymes, EXOZ
Finished products of eXoZymes Inc

Professional capital evaluates the profile of eXoZymes Inc (EXOZ) through net earnings per share dynamics. This metric measures the quarterly profit growth rate relative to previous periods. By tracking quarterly EPS growth, investors determine the speed of the market revaluation of the proprietary biofuel synthesis technology. Sharp peaks in the indicator often reflect speculative demand rather than fundamental progress, while a stable trend confirms the resilience of the unique cell-free enzyme niche.

Competing companies

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|ORMP: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ABVC (ABVC BioPharma, Inc)|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FibroGen Corp (FGEN) - Year-over-year net earnings per share growth for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Year-over-year earnings per share growth for the last twelve months|Rani Therapeutics (RANI) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Synergy CHC Corp.|Earnings per share growth in annualized terms for the last twelve months rallybio.com RLYB|Quarterly EPS earnings growth LEXX|PULM: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings Ltd - Year-over-year net earnings per share growth for the last 12 months|APM - Year-over-year net earnings per share growth for the last 12 months|LYRA - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Year-over-year earnings per share growth for the last twelve months|cbdMD Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth LIPO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)